1. Home
  2. ADIL vs KITT Comparison

ADIL vs KITT Comparison

Compare ADIL & KITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADIL
  • KITT
  • Stock Information
  • Founded
  • ADIL 2010
  • KITT 2014
  • Country
  • ADIL United States
  • KITT United States
  • Employees
  • ADIL N/A
  • KITT N/A
  • Industry
  • ADIL Biotechnology: Pharmaceutical Preparations
  • KITT Industrial Machinery/Components
  • Sector
  • ADIL Health Care
  • KITT Industrials
  • Exchange
  • ADIL Nasdaq
  • KITT Nasdaq
  • Market Cap
  • ADIL 6.5M
  • KITT 6.3M
  • IPO Year
  • ADIL 2018
  • KITT N/A
  • Fundamental
  • Price
  • ADIL $1.12
  • KITT $0.91
  • Analyst Decision
  • ADIL Strong Buy
  • KITT
  • Analyst Count
  • ADIL 1
  • KITT 0
  • Target Price
  • ADIL $8.00
  • KITT N/A
  • AVG Volume (30 Days)
  • ADIL 203.6K
  • KITT 3.2M
  • Earning Date
  • ADIL 11-13-2024
  • KITT 11-12-2024
  • Dividend Yield
  • ADIL N/A
  • KITT N/A
  • EPS Growth
  • ADIL N/A
  • KITT N/A
  • EPS
  • ADIL N/A
  • KITT N/A
  • Revenue
  • ADIL N/A
  • KITT $2,399,852.00
  • Revenue This Year
  • ADIL N/A
  • KITT $980.78
  • Revenue Next Year
  • ADIL N/A
  • KITT N/A
  • P/E Ratio
  • ADIL N/A
  • KITT N/A
  • Revenue Growth
  • ADIL N/A
  • KITT N/A
  • 52 Week Low
  • ADIL $0.77
  • KITT $0.85
  • 52 Week High
  • ADIL $4.17
  • KITT $28.76
  • Technical
  • Relative Strength Index (RSI)
  • ADIL 55.23
  • KITT 37.21
  • Support Level
  • ADIL $1.05
  • KITT $1.00
  • Resistance Level
  • ADIL $1.27
  • KITT $1.08
  • Average True Range (ATR)
  • ADIL 0.09
  • KITT 0.12
  • MACD
  • ADIL -0.00
  • KITT -0.00
  • Stochastic Oscillator
  • ADIL 46.88
  • KITT 0.88

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

About KITT Nauticus Robotics Inc.

Nauticus Robotics Inc develops autonomous robots for the ocean industries. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing of related software to both the commercial and defense business sectors. Nauticus' services provide customers with the necessary data collection, analytics, and subsea manipulation capabilities to support and maintain assets while reducing their operational footprint, operating cost, and greenhouse gas emissions, to improve offshore health, safety, and environmental exposure.

Share on Social Networks: